winner 777 casino login

Lewiston’s Central Maine Healthcare hires orthopedic providerFuture Vision II Acquisition Corp. Announces Entering into Amendment No. 1 to Merger Agreement with Viwo Technology Inc.

New York, NY, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (Nasdaq: GLLI, GLLIW, GLLIR, GLLIU) (" Globalink ” or the " Company ”), a special purpose acquisition company, announced today that its stockholders approved amendments to its charter and trust agreement to extend the deadline to complete its initial business combination and change the structure and cost of such extensions. Under the amended charter, Globalink may extend the deadline to complete its initial business combination by up to six (6) monthly extensions, from December 9, 2024 to June 9, 2025 by depositing $60,000 into its trust account (the " Trust Account ”) with Continental Stock Transfer and Trust Company (" Continental ”). Globalink's stockholders, at a special meeting of its stockholders held on December 3, 2024, approved an amendment to Globalink's Amended and Restated Certificate of Incorporation, as amended (the " Charter Amendment ”), and Globalink's Investment Management Trust Agreement, as amended, originally entered into on December 6, 2021 with Continental (the " Trust Agreement Amendment ”) to extend the deadline to complete Globalink's initial business combination from December 9, 2024 to up to June 9, 2025 for up to six times of monthly extensions, by depositing into the Trust Account $60,000 prior to each one-month extension. The Charter Amendment triggered a right of Globalink's public stockholders to demand the redemption of their public shares out of funds held in the Trust Account. Holders of 2,285,056 public shares properly requested redemption leaving 277,511 public shares outstanding. After payment of the redemption price to the redeeming public shareholders of approximately $11.77 per share for an aggregate of $26.89 million, Globalink will have approximately $3.27 million left in its Trust Account. As a consequence of the adoption of the Charter Amendment and the Trust Agreement Amendment and the redemptions, Globalink can now obtain up to six monthly extensions, or up until June 9, 2025, to complete its initial business combination at a cost of $60,000 per extension. About Globalink Investment Inc. Globalink is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although there is no restriction or limitation on what industry or geographic region, Globalink intends to pursue targets in North America, Europe, South East Asia, and Asia (excluding China, Hong Kong and Macau) in the technology industry, specifically within the medical technology and green energy sectors. Cautionary Statement Regarding Forward-Looking Statements Certain statements in this press release are "forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. In some cases, forward-looking statements can be identified by terminology such as "may,” "will,” "could,” "would,” "should,” "expect,” "plan,” "anticipate,” "intend,” "believe,” "estimate,” "predict,” "potential,” "outlook,” "guidance” or the negative of those terms or other comparable terminology. These statements are based on the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause future events to differ materially from those in the forward-looking statements, many of which are outside of the Company's control. These factors include, but are not limited to, a variety of risk factors affecting the Company's business and prospects, see the section titled "Risk Factors” in the Company's Prospectus filed with the SEC on December 6, 2021 and subsequent reports filed with the SEC, as amended from time to time. Any forward-looking statements are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Globalink Contact: Say Leong Lim Globalink Investment Inc. Telephone: +6012 405 0015 Email: [email protected]FORMER Vice-President, Cde Phelekezela Mphoko, died in India yesterday afternoon at the age of 84 while receiving medical treatment. Acknowledging his dedicated contributions to Zimbabwe’s liberation and growth, the Zanu-PF Politburo promptly honoured him by declaring him a national hero. He is survived by wife, Laurinda, three children, Sikhumbuzo, Siduduzo and Siqokoqela, as well as several grandchildren. Family member Velile Mphoko said the former Vice-President’s wife and children were in Dubai and preparing to fly back home. “Senior family members have instructed us not to allow anyone into the house,” he told Saturday Chronicle at the Mphoko family home in Douglasdale suburb, Bulawayo, yesterday evening. President Mnangagwa expressed deep grief and sadness at the passing of the former Vice-President. “A veteran of our Liberation Struggle, Cde Mphoko’s political and military history coincides with the early days of militant nationalism against white settler colonialism, which later morphed into the armed Liberation Struggle. He was among its early architects, brave fighters, and formative commanders,” said President Mnangagwa. The President stressed that the national hero’s contribution to the liberation struggle can hardly be overstated. “Trained in many countries, including in the then Soviet Union, Cde Mphoko specialised in logistics, an onerous and sensitive responsibility which ensured huge consignments of assortments of arms of war were moved to different bases in the rear, and the war front inside the country in order to maintain the momentum of the Armed Liberation Struggle and to exert ever-mounting pressure on the settler regime until final victory. “A versatile cadre, Cde Mphoko would later join Zapu’s liaison department, a role which took him to Maputo, Mozambique, where the then Zanu was headquartered. We worked very closely with him, laying the groundwork and anticipating the eventual convergence of the two liberation movements into the Patriotic Front,” said President Mnangagwa. He noted that Cde Mphoko’s latter career as an ambassador was moulded by his early exposure to diplomacy during the liberation struggle. “It was an illustrious career which peaked with his appointment as Zimbabwe’s ambassador to various key countries, including the Russian Federation. On behalf of the Party Zanu-PF, Government, my family, and on my behalf, I wish to express my deepest, heartfelt condolences to the Mphoko family, especially to Mrs Mphoko and the children, on this their saddest loss,” said the President. In recognition of Cde Mphoko’s meritorious role of service to his country, the former Vice -President has been declared a national hero. “The Zanu-PF Politburo has unanimously decided and agreed to celebrate and immortalise his life of sacrifice by according him the status of National Hero. May his dear soul rest in eternal peace.” Cde Mphoko was appointed Vice-President in 2014, replacing Cde John Landa Nkomo, who died in 2013. Cde Mphoko was born on June 11, 1940, at Gwizane in Bubi District, Matabeleland North. The former Vice-President was arrested in 1963 for political violence after lashing out at a Rhodesian police officer who had set his dog on him and fellow youths. He was sentenced to three years in jail and sent to Khami Prison. He was a delegate at the Cold Comfort Farm People’s Caretaker Council Congress in the same year. The Congress created a Special Affairs Department and decided on an external wing of Zapu that would plan and direct the armed struggle. Under the Special Affairs programme, Cde Mphoko, along with Albert Nxele, Walter Mbambo, and Sam Dumaza Mpofu, was selected by Zapu leader Cde Joshua Nkomo to go for military training. On April 4, 1964, while awaiting a retrial, Cde Mphoko left Zimbabwe as part of a group of six and received military training in the Soviet Union between May 1964 and February 1965. In March 1965, he created the first military command structure, the Military Planning Committee, to plan and direct the armed struggle. He was one of the first seven commanders commissioned by the revolution and the political leadership to recruit, train, and command Zimbabweans into a revolution for the liberation of Zimbabwe. In 1967, he became a member of the Joint Military Command in charge of Logistics and Supply in the ANC/Zapu Alliance. He commanded the Joint Military rehearsals for the Wankie operations at Dan Nang base, Luthuli Camp, which included South African freedom fighters Joe Modise and Chris Hani, who was the commander of the Detachment, among others. In 1967 and 1968, he operated in Sipolilo (now Guruve) together with Modise, Abraham Nkiwane, Dumiso Dabengwa and others. In 1976, he was a delegate at the formation of the Patriotic Front in Maputo, Mozambique, with Jason Ziyaphapha Moyo, George Silundika, and Joseph Msika. In 1977, Cde Mphoko attended the OAU Adhoc Committee of Foreign Ministers in Luanda, Angola, with Cdes Msika and Silundika. In 1979, he attended the Lancaster House Peace Talks as a military delegate. In 1980, Cde Mphoko was appointed as a Special Envoy for Dr Joshua Nkomo to President Samora Machel of Mozambique, King Sobhuza II of Swaziland, Chief Leabuwa Jonathan of Lesotho, President Fidel Castro of Cuba, and Eric Honneker of the German Democratic Republic. He served in the sub-committee that designed the national flag of the new Republic of Zimbabwe. In 1981, Cde Mphoko worked in the Ministry of Labour and Social Welfare as Deputy Director for Demobilisation. In 1987, he was transferred to the diplomatic service, with junior stints in Mozambique as Liaison Officer, and in 1996, he was appointed Liaison Officer to Austria, also covering the United Nations Drug Control Programme and the Comprehensive Nuclear-Test-Ban Treaty Organisation. In 2002, he was appointed Zimbabwe’s Ambassador to Botswana, before becoming Zimbabwe’s Ambassador to the Russian Federation. Zvamaida Murwira and Remember Deketeke PRESIDENT Mnangagwa, who is also Chancellor of all State universities, yesterday capped 3 320 graduates from the Zimbabwe Open University (ZOU), with the institution saying it will start producing bio-methane gas as part of its contribution to address the energy gap that has affected the country owing to the El [...] Patrick Chitumba, AFTER successfully hosting the inaugural SADC Regional Construction Summit, Zimbabwe Building Contractors Association (ZBCA) president, Dr Tinashe Manzungu, has revealed ambitious plans for the sector to establish itself as a major player in the region. This vision aligns with the industry’s broader objective of bolstering Zimbabwe’s economic growth and development. Zimbabwe’s construction [...] Ashley Phiri, DEPUTY Minister of Higher and Tertiary Education, Innovation, Science and Technology, and Bubi Member of Parliament, Simelisizwe Sibanda, has stressed the urgent need for collective action to address the ongoing HIV/Aids crisis. Speaking at the Matabeleland North World Aids Day commemorations, themed “Take the Rights Path — my health, my rights, our [...]

By Steve Benen After Elon Musk helped derail a bipartisan spending bill with misinformation , Rep. Richie Neal made no effort to hide his frustration . The Massachusetts Democrat — the ranking member on the powerful House Ways and Means Committee — asked, “Can you imagine what the next two years will be like if every time that Congress works its will, and then there’s a tweet, or from an individual who has no official portfolio, who threatens members on the Republican side with a primary, and they succumb?” The billionaire apparently wasn’t pleased with the congressman’s comments, declaring soon after that he would soon “be funding moderate candidates in heavily Democrat districts, so that the country can get rid of those who don’t represent them, like this jacka--.” Whether Musk is aware of this or not, Neal is already widely seen as a moderate, and there’s no reason to believe a primary rival backed by the world’s wealthiest individual would fare any better against the longtime lawmaker. But in the case of Democratic Rep. Rosa DeLauro of Connecticut, a primary challenge apparently isn’t good enough for the billionaire: Musk wants her to be kicked out of Congress altogether. As CNBC reported , at the heart of the story is a change made to the stopgap spending bill designed to prevent a government shutdown last week. House Democrats Jim McGovern of Massachusetts and Rosa DeLauro of Connecticut say their Republican colleagues in Congress caved to the demands of Elon Musk, sinking a bipartisan government funding bill that would have regulated U.S. investments in China. In the original, bipartisan spending agreement — the one that Musk helped kill — there was a provision designed to restrict U.S. investments in China , specifically related to investments in the artificial intelligence and technology sectors. When the legislation was rewritten, Republican took this provision out for reasons GOP officials haven’t fully explained. Ostensibly, the party was looking to make the bill cheaper, but this measure cost effectively nothing. In a series of online items , McGovern complained that the removed provision “would have made it easier to keep cutting-edge AI and quantum computing tech — as well as jobs — in America.” The Massachusetts Democrat added, “But Elon had a problem.” McGovern went on to write, “His bottom line depends on staying in China’s good graces. He [Musk] wants to build an AI data center there too — which could endanger U.S. security. He’s been bending over backwards to ingratiate himself with Chinese leaders.” DeLauro went a bit further, writing a letter to congressional leaders questioning whether the change to the bill reflected some kind of behind-the-scenes corruption: Perhaps, the Connecticut Democrat alleged, the legislation was tweaked specifically to benefit Musk, who has, as DeLauro put it, “extensive” business interests in China. It was, to be sure, a provocative allegation. But the billionaire megadonor responded with an online item of his own , calling DeLauro an “awful creature” and saying that he believes the Democratic congresswoman “needs to be expelled from Congress!” For the record, members of Congress are allowed to raise concerns about possible corruption, just as they’re able to make allegations regarding prominent public figures. Whether the congresswoman’s allegations have merit or not, to suggest that an elected lawmaker be kicked out of office for criticizing a billionaire in ways he doesn’t like is, to put it mildly, unsettling. Steve Benen is a producer for "The Rachel Maddow Show," the editor of MaddowBlog and an MSNBC political contributor. He's also the bestselling author of "Ministry of Truth: Democracy, Reality, and the Republicans' War on the Recent Past."Sen. John Fetterman (D-PA) compared President-elect Donald Trump’s business records case and Hunter Biden’s gun trial as both being illegitimate, stating “pardons are appropriate” for both. “The Trump hush money and Hunter Biden cases were both bulls**t, and pardons are appropriate,” Fetterman wrote in his first post on Truth Social. “Weaponizing the judiciary for blatant, partisan gain diminishes the collective faith in our institutions and sows further division.” Fetterman’s post comes after he previously said during an interview on ABC News’s The View , that Hunter Biden’s gun trial was “politically motivated.” Fetterman added that Trump’s business records case “was political as well.” “I think it’s undeniable that the case against Hunter Biden was really politically motivated, but I also think it’s true that the trial in New York for Trump, that was political as well,” Fetterman said. “And in both cases, I think a pardon is appropriate and I really think collectively, America’s confidence in these kind of institutions have been damaged by these kinds of cases, and we cannot allow these kinds of institutions to be weaponized against our political opponents.” Fetterman’s words come after President Joe Biden revealed that he had “signed a pardon” for his son, Hunter. The “full and unconditional pardon” of Hunter covers “those offenses against the United States which he has committed or may have committed or taken part in during the period from January 1, 2014 through December 1, 2024.” Truth Social is the social media platform where Trump primarily posts statements and reactions to current events. As an owner, Trump’s net worth grew by billions when the company merged with the publicly-traded Digital World Acquisition Corp. to become Trump Media & Technology Group in March of this year. Fetterman is the first Democrat U.S. Senator to join the platform, according to Politico . Other prominent Democrat accounts on Truth Social include California Gov. Gavin Newsom and Kamala Harris’s presidential campaign.Federal appeals court upholds law requiring sale or ban of TikTok in the US

TEAMGROUP presents the latest T-FORCE XTREEM CKD DDR5 desktop memory - Tech Critter

Nvidia supplier Ibiden weighs faster expansion to meet AI demandnational team captain was forced off the field with an injury during the first half of 's to on Friday. The 26-year-old was replaced by in the 38th minute of the match at Atalanta's Gewiss Stadium after being fouled by midfielder Mario Pašalić. The American sat down on the ground in pain, touching an ankle and calf. After attempting to play through the discomfort, he signaled to the bench for a substitution. Pulisic was then helped off the field and replaced with the score tied at 1-1. scored a late winner for Atalanta that sent the hosts top of Serie A and stretched their winning streak to nine games in all competitions. In his second season with Milan, Pulisic has scored eight goals and provided six assists in 19 games. Pulisic's injury is a concern for his club ahead of a crucial Champions League match against next Wednesday.HOUSTON (AP) — Rockets forward Amen Thompson threw Heat guard Tyler Herro to the floor to trigger an altercation that resulted in six ejections in the closing minute of Miami's 104-100 victory over Houston on Sunday. Thompson and Herro became entangled with Miami about to inbound the ball leading 99-94 with 35 seconds left. Thompson grabbed Herro by the jersey and tossed him, with referee Marc Davis describing it as Thompson “body slams Herro .” “I didn’t see it live, but I re-watched it,” Rockets coach Ime Udoka said. “They were in each other’s face, bumping chests a little bit, and one guy’s stronger than the other.” Herro, Thompson, and Udoka were ejected, as were Heat guard Terry Rozier, Rockets guard Jalen Green, and Rockets assistant coach Ben Sullivan. Davis said Green and Rozier escalated the altercation, while Sullivan was assessed a technical foul and ejected for unsportsmanlike comments as the referee was trying to redirect the Rockets' Alperen Sengun. The altercation occurred after Miami had come from 12 points down in the second half to regain the lead with the help of Houston missing 11 straight shots in the fourth quarter. Herro keyed the comeback, leading all scorers with 27 points and adding nine assists and six rebounds. He believed that's what frustrated Thompson. “Guess that’s what’s happens when someone’s scoring, throwing dimes, doing the whole thing,” Herro said. “I’d get mad, too.” Herro said he had never spoken to Thompson, who did not talk to reporters after Sunday’s game, so there was no previous bad blood between the two. “Just two competitors going at it, playing basketball,” Herro said. “It was a regular game that we were playing throughout.” Houston's Fred VanVleet had been ejected just before the fight, with Davis saying VanVleet made contact with him after being called for a 5-second violation. The win for Miami came 24 hours after losing 120-110 in Atlanta. The Heat were missing second-leading scorer Jimmy Butler for a fifth straight game, so Herro was proud of his team played against one of NBA’s best teams this season. “They’re top two, three in the West,” Herro said. “Very good defense. Got a bunch of young, athletic guys that can really play, so that’s a good win for us. That’s a stepping stone. We go 2-1 on the road. Put ourselves in a position to win yesterday, and I like how it’s going. We just got to continue to keep getting better.”

Kurtenbach: Do the 49ers have any pride? We’re about to find out

TTM Technologies, Inc. Introduces Innovative Radio Frequency Components for Telecom Band n104 to Enhance 5.5G ApplicationsAziz Shamuratov Listen below or on the go on Apple Podcasts and Spotify The department store chain accepts at $6.5B buyout offer. (0:16) The Container Store files for Chapter 11 . (1:15) U.K. looks to facial recognition to limit social media use. (4:46) This is an abridged transcript of the podcast. Our top story so far. Department store chain Nordstrom ( NYSE: JWN ) has accepted a $6.25 billion all-cash buyout offer to end its 53-year run as a publicly traded company. Operators signed a deal with Erik, Pete, Jamie Nordstrom and other members of the Nordstrom family and El Puerto de Liverpool, S.A.B. de C.V. ( OTCPK:ELPQF ). Following the close of the transaction, the Nordstrom family will have a majority ownership stake in the company. Common shareholders will receive $24.25 per share. In addition, the board intends to authorize a special dividend of up to $0.25 per share immediately before and contingent on the close of the transaction. Nordstrom first went public in August 1971. At that time, it offered shares under the name "Nordstrom Best" and was recognized as the West Coast's largest volume fashion specialty store shortly thereafter, with annual sales surpassing $100 million by 1973. The company then formally changed its name to Nordstrom, Inc. Shares of the retailer peaked in 2015. In addition, the Container Store Group ( OTC:TCSG ) filed for Chapter 11 after 46 years in business. The company plans to implement a recapitalization transaction to bolster its financial position, fuel growth initiatives, and drive enhanced long-term profitability. CEO Satish Malthora said, "The Container Store is here to stay. Our strategy is sound, and we believe the steps we are taking today will allow us to continue to advance our business, deepen customer relationships, expand our reach, and strengthen our capabilities." Looking to the economy, November durable goods orders (moved a day earlier due to the shortened trading day on Christmas Eve) sank more than expected. New orders of durable goods fell -1.1% M/M , reversing from a 0.8% increase in October, which was revised up from 0.2%. The forecast was for a drop of -0.3%. Core durable goods, which excludes transportation, saw orders tick down -0.1% vs. a 0.2% rise in October and a +0.3% rise expected. Nondefense new orders for capital goods dipped 0.3% during the month. Pantheon Macroeconomist Samuel Tombs notes: “A slump in aircraft orders was responsible for nearly all the drop in headline durable goods orders. In addition, orders ex-transportation were held back by a 12% decline in defense orders.” “The somewhat better performance of orders compared to shipments in November might reflect businesses starting to place orders for delivery in a few months time, in order to lock in prices ahead of potential import tariffs.” In addition, the Conference Board’s measure of consumer confidence unexpectedly fell to 104.7 in December from 112.8 in November. Economists predicted a small rise to 113 with a change in the White House ahead. But the Expectation Index sank 12.6 points to 81.1 points, just above the threshold of 80 that usually signals a recession ahead. The Present Situation Index fell by 1.2 points to 140.2, and Tombs said: “Households have become more downbeat on future business and employment conditions, as well as income expectations. The cutoff for the survey was December 16, before the FOMC meeting and the associated drop in stock prices, so we think the deterioration likely reflects the incoming administration starting to talk about spending cuts, which were not part of Mr. Trump's election pitch.” Among active stocks today, the fact that a federal jury ruled in favor of Qualcomm ( QCOM ) on two of three counts in its lawsuit with Arm Holdings ( ARM ) is seen as a "clear win" for the San Diego-based chipmaker. Bernstein analyst Stacy Rasgon says, "At this point Qualcomm’s roadmap (and their license?) appear safe." Perhaps most importantly, the third question that the jury decided on — whether Qualcomm's CPUs that use designs from Nuvia are licensed under Qualcomm's Arm architectural license — was a big decisive victory, Rasgon added. Xerox ( XRX ) said it will acquire Lexmark International from Ninestar , PAG Asia Capital and Shanghai Shouda Investment Centre in a $1.5 billion deal. The deal is expected to be immediately accretive to earnings per share and free cash flow. And ResMed ( RMD ) and Inspire Medical Systems ( INSP ), two companies reliant on sleep apnea devices, are under pressure after Eli Lilly's ( LLY ) Zepbound gained an additional indication for sleep apnea in obese individuals . ResMed is a top manufacturer of CPAP machines, considered the gold standard treatment for sleep apnea. Inspire makes a neurostimulation implant for sleep apnea. In other news of note, social media companies will be expected to remove millions of underage users from their platforms using facial recognition age checks, according to John Higham, head of online safety policy at the U.K.'s communications watchdog Ofcom. Apps like Meta's ( META ) Facebook, Instagram, TikTok ( BDNCE ), and Snapchat ( SNAP ) could face multi-billion-pound fines under the Online Safety Act if they fail to protect children from harmful content online. According to Ofcom estimates, around 60% of children aged 8-11 years - about 1.6M kids - in the U.K. have social media accounts despite the apps having a minimum 13-year age limit. And a third of children aged 5-7 are reportedly using social media unsupervised. Higham said in a newspaper interview: "It doesn't take a genius to work out that children are going to lie about their age," adding that Ofcom will announce plans next month detailing how apps would be expected to handle the issue. "The sort of thing we might look to is some facial age estimation technology that we see companies bringing in now, which we think is really pretty good at determining who is a child. We will expect the technology to be highly accurate and effective," he said. And in the Wall Street Research Corner, Goldman’s equity team introduced a model to pick industries that are poised to outperform an equal-weighted index by 5 percentage points or more “to identify ‘high conviction’ views with significant alpha potential.” Strategist David Kostin says: “Our model incorporates macro, fundamental, and valuation data as independent variables. We run the profit model for each sector separately and only include variables with statistical and economic significance. Our model does not capture fiscal policy changes or secular themes such as artificial intelligence.” The model's highest-conviction picks are in materials and in software and services, while it also currently recommends Overweights in health care, utilities and real estate. “Our model recommends a large number of defensive Overweights in part because of the level of economic growth optimism already priced into the equity market today,” Kostin said. Among the value stock picks in those sectors are Akamai ( AKAM ) and IBM ( IBM ) in software, Mosaic ( MOS ) and Eastman Chemical ( EMN ) in Materials, NRG Energy ( NRG ) and ConEd ( ED ) in Utilities and Biogen ( BIIB ) in Healthcare. Growth names include Palantir ( PLTR ) and ServiceNow ( NOW ) in software, FreeportMcMoRan (FRE) in Materials, Realty Icome ( O ) in Real Estate and Merck ( MRK ) and Lilly ( LLY ) in Healthcare. Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.Kyiv’s former military commander in chief said the direct involvement of Russian allies in Ukraine means that World War III has officially begun. “I believe that in 2024 we can absolutely believe that the Third World War has begun,” former military chief Valery Zaluzhny warned Thursday, according to Politico . Zaluzhny, who now serves as Ukraine’s envoy to the UK, said Kyiv’s conflict is now on a global scale following the deployment of North Korean troops in Russia earlier this month. Along with the presence of North Korean and Iranian weapons on the frontlines, Zaluzhny said his nation was besieged by international forces, urging Kyiv’s allies to respond in kind. “It is obvious that Ukraine already has too many enemies. Ukraine will survive with technology, but it is not clear whether it can win this battle alone,” he said. Zaluzhny’s grim warning came during the second Ukrainska Pravda’s UP100 award ceremony, which celebrates 100 leaders of Ukrainian civil society, politics, military, business, sports and culture. The former military chief’s warning carries weight in Kyiv given his success in fighting off the initial Russian invasion in 2022, despite his ouster earlier this year amid growing tensions with Ukrainian President Volodymyr Zelensky. The speech comes as the war saw a significant escalation this week, with Russia firing a new kind of ballistic missile at Ukraine on Thursday. Russian President Vladimir Putin claimed his forces fired a medium-range, hypersonic missile at a facility in Dnipro, correcting initial reports that a full intercontinental ballistic missile was used. “This is a clear and severe escalation in the scale and brutality of this war,” Zelensky said of the attack on one of Ukraine’s largest cities. Putin said the missiles would be used against any nation arming Ukraine, a clear warning to the US and UK, which have greenlit Kyiv’s use of their long-range weapons in Russia. As the heavy fire increases, Moscow has also amassed 50,000 Russian and North Korean soldiers in the Kursk region to try and take back the territory from Ukraine. Kyiv had launched a surprise counter-invasion in Kursk over the summer, capturing dozens of towns and transport hubs that humiliated the Kremlin’s forces. The presence of more than 10,000 North Korean troops in Moscow was cited by US and UK officials as the key catalyst for their decision to approve long-range weapon attacks into Russia. With Post wires

Despite a recent market correction, RVNL and Tata Power stocks, previously strong performers, have shown declines. An expert analysis suggests potential upside for RVNL, with a buy recommendation above Rs 463 targeting Rs 550, but advises a stop-loss at Rs 408. For Tata Power, a buy range of Rs 397-410 is suggested, targeting Rs 490-500, with a stop-loss at Rs 370. New Delhi: Many Railway and power sector stocks have given strong returns to their investors in the last one year. However, the shares recorded a certain amount of decline during the recent ‘market correction’. Two stocks – Rail Vikas Nigam Limited (RVNL) and Tata Power have given bumper returns to the shareholders. However, these two counters also witnessed a drop. RVNL share price target RVNL shares have recorded a continuous decline in the recent months. The railway stock is tagged as a multibagger and is very popular amongst the investors. Recently, the scrip had increased to the level of Rs 480, but from there it is continuously falling. In the last one year, this stock has given returns of more than 130 per cent. On December 27, 2024 RVNL share price closed at Rs 425.25. Commenting on the RVNL share price, Sharad Mishra, CIO of sharadmishra.com, said that a good breakout was seen in RVNL shares. Its financial results were also good. However, despite this the stock did not move. He said that this happened due to market weakness. The strike base of the stock is around Rs 408. Those who have RVNL shares should maintain a Stop Loss at Rs 408. If it goes below this, you can sell the position. He said that a big move in the stock can come if it reaches Rs 463. If the stock sustains its movement at this levels, it can go up to Rs 550. He advised the investors to buy the stock when there is a big upside move in the stocks. Tata Power share price target Giving his opinion on Tata Power stock, the market expert said that a broad top pattern is being formed inside Tata Power and interested investors can purchase the stock in the range of Rs 397-Rs 410. Stop loss can positioned at Rs 370, he added. Mishra advised the Tata Power shareholders to sell their positions if it closes below Rs 370. This zone has been tested many times. “If you see, this zone test has been done several times after around April 2024. Next its elid web takes it towards Rs 457 to Rs 460. If you hold some position, you can see targets of Rs 490 to 500,” the expert added. ( Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO and Mutual Funds .) Click for more latest Markets news . Also get top headlines and latest news from India and around the world at News9. Biplob Ghosal is Online News Editor (Business) at TV9’s digital arm - News9live.com. Leading the english business editorial team, he writes on various issues related to stock markets, economy and companies. Having over a decade of experience in financial and political journalism, Biplob has been previously associated with Timesnownews.com, Zeenews. He is an alumnus of Makhanlal Chaturvedi Rashtriya Patrakarita Vishwavidyalaya. Follow him at @Biplob_ghosal.( MENAFN - GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Knee Osteoarthritis pipeline constitutes 50+ key companies continuously working towards developing 60+ Knee Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Knee Osteoarthritis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. “Knee Osteoarthritis Pipeline Insight, 2024 " report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Knee Osteoarthritis Market. Some of the key takeaways from the Knee Osteoarthritis Pipeline Report: Companies across the globe are diligently working toward developing novel Knee Osteoarthritis treatment therapies with a considerable amount of success over the years. Knee Osteoarthritis companies working in the treatment market are Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, and others, are developing therapies for the Knee Osteoarthritis treatment Emerging Knee Osteoarthritis therapies in the different phases of clinical trials are- M6495, PPV 06, LG00034053, StroMel, TTAX03, EP-104IAR, OLP 1002, JTA-004, X 0002, Lorecivivint, and others are expected to have a significant impact on the Knee Osteoarthritis market in the coming years. In September 2024, Cytonics has announced the completion of subject enrollment for its Phase I clinical trial of CYT-108, a potential disease-modifying therapy for knee osteoarthritis (OA). CYT-108 is a recombinant variant of the alpha-2-macroglobulin blood serum protease inhibitor. The company initiated this Phase I trial in July, which is a first-in-human, multicenter, six-month, double-blind, randomized controlled trial (RCT) aimed at evaluating the safety and efficacy of CYT-108 in patients with unilateral, mild-to-moderate primary OA of the knee. In June 2024, Enlivex Therapeutics Ltd. (Nasdaq: ENLV) , a clinical-stage company focused on macrophage reprogramming immunotherapy, announced a positive interim data update from a Phase I/II investigator-initiated clinical trial of Allocetra in patients with end-stage knee osteoarthritis who were candidates for knee replacement surgery. Knee Osteoarthritis Overview Knee osteoarthritis is a degenerative joint disease that occurs when the protective cartilage in the knee joint wears down over time. This leads to pain, stiffness, swelling, and reduced mobility. The condition is most common in older adults but can also affect younger individuals due to injury or genetic factors. Risk factors include age, obesity, previous knee injuries, and family history. Symptoms often worsen with activity and improve with rest. Treatment options include physical therapy, pain management with medications, lifestyle changes like weight loss, and in severe cases, surgical interventions such as knee replacement. Get a Free Sample PDF Report to know more about Knee Osteoarthritis Pipeline Therapeutic Assessment- Emerging Knee Osteoarthritis Drugs Under Different Phases of Clinical Development Include: M6495: Merck KGaA PPV 06: Peptinov LG00034053: LG Chem StroMel: Akan Bioscience TTAX03: BioTissue,Inc. EP-104IAR: Eupraxia Pharmaceuticals Inc. OLP 1002: OliPass Corporation JTA-004: Bone Therapeutics X 0002: Techfields Pharma Lorecivivint: Biosplice Therapeutics Knee Osteoarthritis Route of Administration Knee Osteoarthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as Oral Parenteral Intravenous Subcutaneous Topical Knee Osteoarthritis Molecule Type Knee Osteoarthritis Products have been categorized under various Molecule types, such as Monoclonal Antibody Peptides Polymer Small molecule Gene therapy Knee Osteoarthritis Pipeline Therapeutics Assessment Knee Osteoarthritis Assessment by Product Type Knee Osteoarthritis By Stage and Product Type Knee Osteoarthritis Assessment by Route of Administration Knee Osteoarthritis By Stage and Route of Administration Knee Osteoarthritis Assessment by Molecule Type Knee Osteoarthritis by Stage and Molecule Type DelveInsight's Knee Osteoarthritis Report covers around 40+ products under different phases of clinical development like Late-stage products (Phase III) Mid-stage products (Phase II) Early-stage product (Phase I) Pre-clinical and Discovery stage candidates Discontinued & Inactive candidates Route of Administration Further Knee Osteoarthritis product details are provided in the report. Download the Knee Osteoarthritis pipeline report to learn more about the emerging Knee Osteoarthritis therapies Some of the key companies in the Knee Osteoarthritis Therapeutics Market include: Key companies developing therapies for Knee Osteoarthritis are - Eli Lilly and Company, Nature Cell Co. Ltd., Novo Nordisk A/S, Flexion Therapeutics, Inc., Grünenthal GmbH, Tissue Tech Inc., Kolon TissueGene, Inc., Bioventus LLC, Akan Biosciences, LLC, Genascence Corporation, Immunis, Inc., Novartis, Biosplice Therapeutics, Sorrento Therapeutics, Inc., Novartis, Celltex Therapeutics Corporation, MiMedx Group, Inc., Rho, Inc., Techfields Pharma Co. Ltd, Saol Therapeutics Inc, Centrexion Therapeutics, Taiwan Liposome Company, MiMedx, Ampio Pharmaceuticals, ReNu, Medipost, and others. Knee Osteoarthritis Pipeline Analysis: The Knee Osteoarthritis pipeline report provides insights into The report provides detailed insights about companies that are developing therapies for the treatment of Knee Osteoarthritis with aggregate therapies developed by each company for the same. It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Knee Osteoarthritis Treatment. Knee Osteoarthritis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. Knee Osteoarthritis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Knee Osteoarthritis market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Download Sample PDF Report to know more about Knee Osteoarthritis drugs and therapies Knee Osteoarthritis Pipeline Market Drivers Increase in prevalence of Osteoarthritis, robust Knee Osteoarthritis Pipeline are some of the important factors that are fueling the Knee Osteoarthritis Market. Knee Osteoarthritis Pipeline Market Barriers However, risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment, high cost associated with the treatment and other factors are creating obstacles in the Knee Osteoarthritis Market growth. Scope of Knee Osteoarthritis Pipeline Drug Insight Coverage: Global Key Knee Osteoarthritis Companies: Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, and others Key Knee Osteoarthritis Therapies: M6495, PPV 06, LG00034053, StroMel, TTAX03, EP-104IAR, OLP 1002, JTA-004, X 0002, Lorecivivint, and others Knee Osteoarthritis Therapeutic Assessment: Knee Osteoarthritis current marketed and Knee Osteoarthritis emerging therapies Knee Osteoarthritis Market Dynamics: Knee Osteoarthritis market drivers and Knee Osteoarthritis market barriers Request for Sample PDF Report for Knee Osteoarthritis Pipeline Assessment and clinical trials Table of Contents 1. Knee Osteoarthritis Report Introduction 2. Knee Osteoarthritis Executive Summary 3. Knee Osteoarthritis Overview 4. Knee Osteoarthritis- Analytical Perspective In-depth Commercial Assessment 5. Knee Osteoarthritis Pipeline Therapeutics 6. Knee Osteoarthritis Late Stage Products (Phase II/III) 7. Knee Osteoarthritis Mid Stage Products (Phase II) 8. Knee Osteoarthritis Early Stage Products (Phase I) 9. Knee Osteoarthritis Preclinical Stage Products 10. Knee Osteoarthritis Therapeutics Assessment 11. Knee Osteoarthritis Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. Knee Osteoarthritis Key Companies 14. Knee Osteoarthritis Key Products 15. Knee Osteoarthritis Unmet Needs 16 . Knee Osteoarthritis Market Drivers and Barriers 17. Knee Osteoarthritis Future Perspectives and Conclusion 18. Knee Osteoarthritis Analyst Views 19. Appendix 20. About DelveInsight About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. MENAFN23122024003238003268ID1109025408 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

An order commuting the death penalty to life in prison without possibility of parole was signed by Joe Biden for 37 of 40 people sentenced to death, he said in a statement posted on the White House website. “Today, President Biden announced that he is commuting the sentences of 37 people on federal death row. These individuals’ sentences will be commuted from the death penalty to life in prison without parole,” the White House said in the announcement. “I have dedicated my career to reducing crime and ensuring a fair and effective justice system. Today, I am commuting the sentences of 37 of the 40 people on death row at the federal level to life in prison without the possibility of parole. These commutations are consistent with my administration’s moratorium on federal executions in cases other than terrorism and hate-motivated mass murders,” Biden said in the statement. “Make no mistake: I condemn these killers, I grieve for the victims of their heinous acts, and I grieve for all the families who have suffered unimaginable and irreparable loss. But guided by my conscience and my experience as a public defender, chairman of the Senate Judiciary Committee, vice president and now president, I am more convinced than ever that we must end the use of the death penalty at the federal level. In good conscience, I cannot stand by and let a new administration continue the executions I stopped,” the outgoing U.S. president added. Explore related questionsMissouri state pension board bans use of fund for political donationsEAST RUTHERFORD, N.J. (AP) — The New York Giants organization got exactly what it deserved in getting blown out by Baker Mayfield and the Tampa Bay Buccaneers. The Giants were embarrassed in Sunday's 30-7 loss , taunted by Mayfield after a touchdown run just before halftime. And then they saw their fans walk out on them again when the Bucs extended their lead to 30-0 and sent New York (2-9) to its sixth straight loss. The losing streak is the longest for the Giants since 2019, when they dropped a franchise-record nine straight games to finish 4-12. That led to the firing of coach Pat Shurmur after two seasons. Third-year coach Brian Daboll is clearly in trouble, with the Giants guaranteed a second straight losing season. They were 6-11 in a 2023 season that featured a lot of injuries. Daboll, who denies he has lost the team, isn't the only one whose job is in jeopardy. General manager Joe Schoen is on the hot seat and so is this entire franchise, which is celebrating its 100th year. It's one thing to lose. It's quite another to give up, and that's what the organization did when it decided to bench Daniel Jones a week ago and then release him on Friday after the 27-year-old asked co-owner John Mara to let him walk away. While he wasn't playing well, Jones was the Giants' best quarterback. He gave them more a of chance to win than either Tommy DeVito or Drew Lock. Removing him from the picture was all but certain to make the Giants worse, even if it was a good business decision. If Jones was hurt and unable the pass his physical before the 2025 season, the team would have been on the hook for a $23 million cap hit. The problem is the players care about now. By getting rid of Jones and elevating DeVito to the starting role, the front office was telling the team it didn't care about winning with seven games left in the season. So the players gave a lackluster effort. Defensive tackle Dexter Lawrence called the team soft. Rookie receiver Malik Nabers said he was sick of losing. Left tackle Jermaine Eluemunor said he saw a lack of effort by some players. What they all were saying was they were angry at being betrayed. Money is never more important than winning, and the Giants made that mistake. What’s working At this point in the season? Nothing. What needs help The offense once again. The Giants have scored a league-low 163 points, including only 60 in six games at MetLife Stadium, where they are winless this season. They have scored in double figures at home twice. Daboll's team has been held scoreless in the first half in three of 11 games and it has been held without a first-half touchdown seven times. Daboll said he will continue to call the offensive plays. Stock up S Tyler Nubin. The rookie has had a team-high 12 tackles in each of the last two games. His 81 tackles for the season are just two behind team leader Bobby Okereke. Stock down RB Tyrone Tracy. The rookie leads Giants running backs with 587 yards on 116 carries — a 5.1-yard average for the fifth-round pick. But holding onto the ball has been a big issue. Tracy's fumble in overtime cost New York a chance to win in Germany against Carolina. He also lost the ball in the third quarter at the Bucs 5-yard line with New York down 23-0. It earned him a seat on the bench. Injuries LT Jermaine Eluemunor (quad) and OLB Azeez Ojulari (toe) left Sunday's game in the first quarter. Chris Hubbard filled in at tackle and the Giants luckily got back DL Kayvon Thibodeaux this past week after he missed five games with a broken wrist. DeVito was banged up but Daboll expects him to start against the Cowboys. Key numbers 10 — The Giants have gone 10 consecutive games without an interception, tying the NFL record held by the 1976-77 San Francisco 49ers and the 2017 Oakland — now Las Vegas — Raiders. The Giants and Raiders now share the single-season mark. What’s next A national showcase on Thanksgiving Day for the NFC-worst Giants at Dallas. ___ AP NFL: https://apnews.com/hub/NFL Tom Canavan, The Associated Press

Juve deepen Man City crisis, Barcelona into Champions League knockouts

Nissan and Honda to attempt a merger that would create the world's No. 3 automakerBlue Ocean Team 1 vs Team Red: A Clash of TitansPresident-elect Trump wants to again rename North America's tallest peak

CEAT Kelani Holdings has broadened the scope of its flagship community initiative promoting road safety around schools by engaging with the Police and the Sri Lanka Corps of Military Police (SLCMP) of the Sri Lanka Army, two institutions that play lead roles in this domain. The company recently presented stocks of traffic management-related signboards and traffic cones to these institutions, as one of its community commitments that makes up the ‘CEAT Cares’ portfolio of community projects. The signboards and traffic cones presented to the Cinnamon Gardens Police Station are to be strategically placed on main roads to facilitate traffic management near schools, government institutions, and other high-traffic areas within the station’s jurisdiction, supporting CEAT’s efforts to help improve road safety and aid law enforcement maintain smooth traffic flows. Meanwhile, the signboards presented to the Military Police of the Sri Lanka Army will facilitate the SLCMP’s role in traffic control and ensuring safety during major national celebrations such as the Independence Day celebrations and national war heroes commemoration ceremonies, as well as events organised by the Sri Lanka Army. An articulation of CEAT’s credo – “Making mobility safer and smarter every day” – the CEAT Cares programme has been sustained by CEAT Kelani Holdings since 2010 and has benefitted 290 schools across the country to date. It involves the presentation of traffic safety equipment to schools located close to main roads and in high congestion zones as part of the company’s continuing commitment to make commuting safer, especially for school children. This flagship community initiative was designed to reflect CEAT’s focus on safety on the roads – a key element in all its products. The largest domestic manufacturer of cross-ply and radial tyres in Sri Lanka, CEAT Kelani Holdings currently manufactures half of the country’s pneumatic tyre requirements, and exports about 20 per cent of its production to 16 countries. The joint venture’s cumulative investment in Sri Lanka over the past decade alone exceeds Rs 8.5 billion.